Stephen Willey
Stock Analyst at Stifel
(3.95)
# 628
Out of 5,113 analysts
126
Total ratings
43.01%
Success rate
14.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $26.85 | +48.98% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $103.57 | +11.04% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $1.78 | +517.98% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $75.91 | +64.67% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $64.76 | +99.20% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $100.38 | +14.56% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.71 | +142.59% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $174.47 | -16.89% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.56 | +96.63% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $43.45 | -5.64% | 19 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $12.65 | +121.34% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.56 | +220.51% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $5.25 | +280.95% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $18.18 | +92.52% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $12.80 | +681.25% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.33 | +201.89% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.00 | +161.18% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.24 | +1,537.33% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.53 | +161.44% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $44.25 | +40.11% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.17 | +74.08% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.06 | +483.94% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.27 | +12,586.67% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.30 | +813.04% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.17 | +243.35% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $407.88 | -69.84% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $79.55 | -40.92% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $62.29 | +74.99% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $20.09 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $9.23 | +149.19% | 5 | Feb 7, 2018 |
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $26.85
Upside: +48.98%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $103.57
Upside: +11.04%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.78
Upside: +517.98%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $75.91
Upside: +64.67%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $64.76
Upside: +99.20%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $100.38
Upside: +14.56%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.71
Upside: +142.59%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $174.47
Upside: -16.89%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.56
Upside: +96.63%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $43.45
Upside: -5.64%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $12.65
Upside: +121.34%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.56
Upside: +220.51%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.25
Upside: +280.95%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $18.18
Upside: +92.52%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $12.80
Upside: +681.25%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.33
Upside: +201.89%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.00
Upside: +161.18%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.24
Upside: +1,537.33%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.53
Upside: +161.44%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $44.25
Upside: +40.11%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.17
Upside: +74.08%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $2.06
Upside: +483.94%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.27
Upside: +12,586.67%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.30
Upside: +813.04%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.17
Upside: +243.35%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $407.88
Upside: -69.84%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $79.55
Upside: -40.92%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $62.29
Upside: +74.99%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $20.09
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $9.23
Upside: +149.19%